There are different approaches to cancer treatment and the partnership between the primary care veterinarian and veterinary oncologist is critical to the successful management of pets with cancer. This segment will delve into the wide array of treatment options that have emerged in the world of cancer care.
Dr. Chelsea Tripp will kick off this segment discussing some newer advancements in care that have fewer side effects than traditional IV chemotherapy. She will introduce us to novel therapies in cancer care such as Gold Nanoparticles and Stelfonta® and explain their applications in treating pets with cancer.
We will then turn our attention to learning about the indications and benefits of cellular therapies, intratumoral therapies, and checkpoint inhibitors.
One means of reducing systemic toxicities associated with chemotherapy is to directly and locally treat a tumor. Dr. Tim Fan will describe a novel anchoring strategy for retaining potent anti-tumor cytokines to their location of injection, thereby exerting potent immune-activating properties locally. He will share results of a trial utilizing this method for treating dogs with malignant melanoma.
We have an exciting addition to our armament for cancer care, and more are on the way! Dr. Doug Thamm will introduce us to immune checkpoint inhibitors and explain how these agents can be used alone and in combination with other forms of cancer treatment. He will highlight which dogs stand most to benefit with this type of therapy.
Registration is FREE for VetVine Premium Membership subscribers.
